It indicates that T2D may result in comparable changes within the pulp to other body tissues. Rats induced with hyperglycaemia show a marked reduction in plasma blood flow within the dental pulp with an increased amount of Anti-Inflammatory Peptide 1 fibrous connective tissue and arteriosclerotic change in the walls of blood vessels (Amatyakul et al., 2003; Garber et al., 2009). This can affect dental pulp repair and healing as evidenced by reduced dentine bridge thickness following direct pulp capping procedures with mineral trioxide aggregate (MTA; Garber et al., 2009). Furthermore, scanning electron microscopy studies have exhibited physicochemical differences in dentine from patients with diabetes, which can negatively influence clinical outcomes. The shear bond strength of composite resin to dentine and enamel is usually reduced in diabetes and within root dentine there is significantly increased dentinal tubular density and diameter (Saghiri et al., 2020, 2021). Together, these increase the potential for persistent contamination from microbial leakage and dentinal tubule invasion. There is increasing evidence of an association between the presence of local pulp and periapical inflammation Anti-Inflammatory Peptide 1 resulting in apical periodontitis, the outcome of root canal Anti-Inflammatory Peptide 1 treatment, tooth loss and T2D (Cabanillas\Balsera et al., 2019; Gupta et al., Anti-Inflammatory Peptide 1 2020; Nagendrababu et al., 2020; Prez\Losada et al., 2020; Segura\Egea et al., 2016, 2019). There is a greater prevalence of periapical lesions in patients with T2D compared with non\T2D patients. Patients with T2D have a greater likelihood of persistent periapical disease following endodontic treatment and significantly more root filled teeth are extracted in patients with systemic disease. Despite this association, the likely presence of confounding variables means it is not possible to define a causal relationship (Segura\Egea et al., 2019). Although T2D can therefore be considered a prognostic factor in the management of advanced pulp disease and endodontic outcomes, what is less clear is usually how the coronal pulp is usually influenced by hyperglycaemia. Clinically, determining the pulp health status is based on subjective and objective clinical findings. Treatment outcomes are variable, and it can be even more challenging for clinicians to diagnose the pulp status needed to guideline treatment decisions and tooth prognosis for KMT2C patients who have associated systemic disease. The recommendations for diagnosing the inflammatory state are the history, clinical examination, pulp sensibility testing (electric and cold) and viewing diagnostically acceptable periapical radiographs (Duncan et al., 2019). The term clinically normal pulp is used to describe an asymptomatic, uninflamed dental pulp that clinically and radiographically has no signs or symptoms of disease (American Association of Endodontists, 2009). Cells within healthy (normal) tissues are necessary for immune surveillance and contribute to healing, but our understanding of the normal morphological appearance of the pulp in a patient with T2D is usually unclear and warrants investigation. Furthermore, an inflammatory response is necessary to initiate healing and there is sparse understanding around the effect of hyperglycaemia on common immune and inflammatory markers within the normal dental pulp. No other studies were identified in the literature which examined the human dental pulp using histology and immunohistochemistry (IHC) techniques and the ease of tissue preparation for T2D tissue samples was unknown, so a pilot study was justified. Therefore, the aim of this study was to investigate and provide preliminary findings on the effect of T2D around the morphology of the dental pulp and the expression of proteins associated with the immune system. The hypothesis was that T2D will result in altered morphology within the clinically normal pulp with increased connective tissue and the proteins associated with the immune system and the pulp will be affected similar to other body sites. METHODS AND MATERIALS Ethics approval for this study was obtained from the University of Otago Human Ethics Committee (Health; Ref. H16/069). This was a pilot study, and patients who were having mature human permanent molar teeth extracted for clinical reasons as part of a treatment plan, and who met the inclusion criteria were selected. Teeth were collected from T2D (ratiovaluevalue .05; ** .01; *** .001 Open in a separate window FIGURE 4 Photomicrograph showing immunolabelling pattern of anti\TLR2, anti\TLR4 and anti\FOXP3 from non\T2D and T2D participants, and positive and negative control samples. Anti\TLR2 staining was only very weakly detected in the odontoblast region (a and b) while moderate anti\TLR4 staining was found (e and f). Strong anti\FOXP3 staining was observed for non\T2D samples around blood vessels (i) while.